In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Drug companies to face first opioid trial following pandemic delays

By Nate Raymond and Brendan Pierson (Reuters)Four drugmakers, including Johnson & Johnson and Teva Pharmaceutical Industries Ltd, will go to trial on Monday over claims they helped fuel an opioid

Audio-only 'virtual' prenatal care not tied to worse perinatal outcomes

By Linda Carroll (Reuters Health) - Pregnant patients who were given the opportunity to have some of their prenatal appointments virtually, as audio-only visits, during the pandemic attended more of

Physical inactivity tied to COVID-19 hospitalizations, ICU admissions, mortality

By Lisa Rapaport (Reuters Health) - Patients with COVID-19 who have been consistently physically inactive have a significantly higher risk of severe outcomes than counterparts who were getting at

Brazil health regulator lacks data needed to evaluate Sputnik V

By Ricardo Brito BRASILIA (Reuters) - Brazil's health regulator Anvisa lacks the information necessary to evaluate the safety and efficacy of Russia's Sputnik V vaccine, the agency said in legal

Chronic pain in women linked to genes

By Marilynn Larkin NEW YORK (Reuters Health) - Women may be at greater risk of experiencing chronic pain at least in part because of their genes, a genome-wide association study (GWAS) suggests. "We

Switch from adalimumab to its biosimilar not tied to drug retention in psoriasis patients

By Marilynn Larkin NEW YORK (Reuters Health) - A mandatory non-medical switch from adalimumab to its biosimilar was not associated with drug retention in a Danish registry study. "This is the largest

Sex-selective abortion continues to widen India's gender divide

By Ronnie Cohen (Reuters Health) - A cultural preference for sons has led to an increasing number of sex-selected abortions throughout India - resulting in as many as 22 million fewer female births

UPDATE 1-J&J scientists refute idea that COVID-19 vaccine's design linked to clots

(Adds FDA investigation into vaccine design in paragraph 5) By Julie Steenhuysen CHICAGO (Reuters) - Scientists at Johnson & Johnson on Friday refuted an assertion in a major medical journal that the

Kyrgyz health minister promotes herbal COVID-19 cure; expert says it's poisonous

By Reuters Staff BISHKEK (Reuters) - Kyrgyzstan will use a herbal tonic to treat COVID-19, its health minister said on Friday after his president praised the remedy - despite warnings from a medical

J&J scientists refute 'class effect' to blame for clots in those who got its COVID-19 vaccine

By Julie Steenhuysen CHICAGO (Reuters) - Scientists at Johnson & Johnson on Friday refuted an assertion in a major medical journal that the adenovirus-based design of their COVID-19 vaccine, which is

U.S. parents begin to ask: Should my child get a COVID-19 shot?

By Gabriella Borter and Michael Erman (Reuters) - Tristen Sweeten, a 34-year-old nurse in Utah, hopes her three children will receive Moderna's COVID-19 vaccine through its pediatric clinical trial.

China's Sinovac vaccine 67% effective against symptomatic infection -Chile report

By Dave Sherwood SANTIAGO (Reuters) - Sinovac's COVID-19 vaccine CoronaVac was 67% effective in preventing symptomatic infection in the first real-world study of the Chinese shot, the Chilean

Italian prosecutor accuses WHO of hindering COVID investigation

By Emilio Parodi MILAN (Reuters) - An Italian prosecutor has accused the World Health Organization (WHO) of hindering efforts to investigate allegations that Italy failed to prepare adequately for the

Digital divide hampers Stockholm vaccinations as elderly struggle to book

By Reuters Staff STOCKHOLM (Reuters) - Thousands of vaccination slots in Stockholm earmarked for Sweden's oldest and frailest people are being passed on to younger patients, with critics accusing the

Brazil scrambles to secure sedatives as hospitals overwhelmed by COVID-19

By Reuters Staff SAO PAULO (Reuters) - An emergency shipment of sedatives needed to intubate severely ill COVID-19 patients arrived in Brazil late on Thursday from China, as the South American country

J&J COVID-19 vaccine pause to be reviewed by U.S. panel next week

By Manas Mishra and Carl O'Donnell (Reuters) - A U.S. panel will meet again next week to discuss whether the pause on the use of Johnson & Johnson's COVID-19 vaccine should continue, after delaying a

Concerns about COVID-19 vaccine hesitancy during Ramadan

By Megan Brooks NEW YORK (Reuters Health) - Concerns are being raised about acceptance of COVID-19 vaccination during Ramadan, the Islamic month of fasting that runs April 12 to May 12. For 1.9

Surveillance, education may help to catch melanomas earlier

By Scott Baltic NEW YORK (Reuters Health) - A longitudinal surveillance program that included skin-cancer screening and education about self-exams was associated with significantly thinner and

Serum uric acid levels tied to hip fracture risks in older people

By David Douglas NEW YORK (Reuters Health) - Increased levels of uric acid may signal a higher risk of hip fracture, according to a large population-based cohort study by researchers in Europe. "Our

Snoring linked to structural brain changes and ADHD-like behaviors in kids

By Megan Brooks NEW YORK (Reuters Health) - Behavioral problems in children who regularly snore may be associated with structural changes in the brain, new research suggests. Studies have shown a

Benefits of voxelotor in sickle cell disease durable

By Reuters Staff NEW YORK (Reuters Health) - The benefits of voxelotor in patients with sickle cell disease are durable, with no new safety signals, according to longer-term data from the HOPE-3 study

Lilly asks FDA to not allow lone use of COVID-19 drug bamlanivimab

By Reuters Staff (Reuters) - Eli Lilly and Co said it had requested cancellation of the U.S. authorization granted to its COVID-19 antibody, bamlanivimab, which will now be used in combination with

'You can't clone us': Polish doctors cry for help as COVID deaths spike

By Joanna Plucinska and Alicja Ptak KRAKOW, Poland (Reuters) - When the pandemic began last year, Kinga Szlachcic-Wyroba, an anaesthesiologist in the Stefan Zeromski Specialist Hospital in Krakow,

ANALYSIS-Countries seek more Moderna, Pfizer/BioNTech COVID-19 shots as concerns mount over rival vaccines

By Carl O'Donnell NEW YORK (Reuters) - Wealthy governments are looking to COVID-19 shots from Pfizer Inc and Moderna Inc to keep their vaccination programs on track, as safety concerns and production

Johnson & Johnson asked rival COVID-19 vaccine makers to probe clotting risks - WSJ

By Reuters Staff (Reuters) - Johnson & Johnson had reached out to rival COVID-19 vaccine makers to join in an effort to study the risks of blood clots, the Wall Street Journal reported on Friday,

Australia reports first blood clot death 'likely' linked to AstraZeneca vaccine

By Swati Pandey SYDNEY (Reuters) - Australia on Friday reported its first fatality from blood clots in a recipient of AstraZeneca's COVID-19 shot, and its regulator said there was a likely link

Physician/gun-owner says doctors must lead charge against gun violence

By Ronnie Cohen (Reuters Health) - Douglas M. DeLong is a hunter, a gun owner and a former member of the National Rifle Association. He is also a physician who feels compelled to do his part to try to

Special considerations for examining hair loss with tightly coiled hair

By Lisa Rapaport (Reuters Health) - Physicians who examine patients with hair loss who have tightly coiled hair should take care to avoid using culturally insensitive language, especially in race and

Fauci says he believes J&J vaccine will 'get back on track soon'

By Julie Steenhuysen CHICAGO (Reuters) - Anthony Fauci, the top U.S. infectious disease doctor, hopes U.S. regulators will make a quick decision to lift a pause on the Johnson & Johnson vaccine and

Androgen receptor deficiency a risk factor for asthma

By Lisa Rapaport (Reuters Health) - People with androgen insensitivity syndrome may be more likely to develop asthma, a new study suggests. Researchers examined data on the prevalence of androgen

Suicide risk higher for nurses compared to general population

By Linda Carroll (Reuters Health) - Compared to the general population, the risk of suicide is higher for nurses - particularly women - but not for doctors, a new study finds. A retrospective analysis

Diet high in animal, processed foods and alcohol, sugar tied to inflamed gut microbiome

By Marilynn Larkin NEW YORK (Reuters Health) - A higher intake of animal and processed foods, alcohol and sugar is associated with higher levels of intestinal inflammatory markers, researchers say. "

Whole-genome sequencing reveals rare variants tied to Alzheimer's disease

By Marilynn Larkin NEW YORK (Reuters Health) - Whole-genome sequencing (WGS) has uncovered rare genetic variants related to Alzheimer's disease (AD), researchers say. "Genome-wide association studies

France outlaws sex with children aged under 15

By Reuters Staff PARIS (Reuters) - The French parliament on Thursday adopted legislation that characterises sex with a child under the age of 15 as rape and punishable by up to 20 years in jail,

UPDATE 1-U.S. preparing for 1-year COVID-19 booster shots; Pfizer chief sees need

(Adds CDC testimony on U.S. vaccinated infections, Pfizer CEO comment) By Reuters Staff (Reuters) - The United States is preparing for the possibility that a booster shot will be needed between nine

Low risk of delayed brain bleed after blunt head trauma in older people on DOAC therapy

By Reuters Staff NEW YORK (Reuters Health) - There is a low risk of delayed intracranial hemorrhage (ICH) in older patients on direct oral anticoagulant (DOAC) therapy who fall and hit their head,

Global officials urge rich countries to donate excess COVID-19 vaccines, money to help end pandemic

By Stephanie Nebehay and Michelle Nichols GENEVA/NEW YORK (Reuters) - Top U.N., financial and vaccine officials on Thursday urged rich countries to donate excess COVID-19 vaccine doses to a program

Brazil's COVID-19 response cost thousands of lives, says humanitarian group

By Reuters Staff RIO DE JANEIRO (Reuters) - The Brazilian government's "failed response" to the pandemic led to thousands of otherwise avoidable deaths and created a humanitarian catastrophe that is

Indian hospitals overwhelmed by COVID surge as beds, oxygen fall short

By Neha Arora and Sachin Ravikumar NEW DELHI (Reuters) - Many Indian hospitals were scrambling for beds and oxygen as COVID-19 infections surged to a new daily record on Thursday, with a second wave

Booster shots may be needed within a year after COVID-19 vaccinations -U.S. official

By Reuters Staff (Reuters) - The United States is preparing for the possibility that a booster shot will be needed between nine to 12 months after people are initially vaccinated against COVID-19, a

Pancreatic-cancer surveillance in people at high risk not tied to better outcomes

By David Douglas NEW YORK (Reuters Health) - Surveillance of people at high hereditary risk for pancreatic ductal adenocarcinoma (PDAC) can lead to diagnosis at an earlier stage, but as yet there is

More tolerable benznidazole treatment regimen for Chagas disease shows promise

By Reuters Staff NEW YORK (Reuters Health) - For treatment of Chagas disease, benznidazole can be taken for a shorter period of time and at lower doses with similar efficacy to the current standard

Novel drug first to improve outcome of metastatic uveal melanoma

By Megan Brooks NEW YORK (Reuters Health) - Compared with available therapies, treatment with tebentafusp significantly improved overall survival in patients with previously untreated metastatic uveal

Most antibody drugs ineffective against Brazil variant

By Reuters Staff (Reuters) - The coronavirus variant first identified in Brazil, known as P.1, is resistant to three of the four antibody therapies with emergency use authorization in the United

Autoimmune disease treatments may reduce vaccine responses

By Reuters Staff (Reuters) - Immunosuppressive drugs for inflammatory diseases like rheumatoid arthritis, multiple sclerosis, and ulcerative colitis can impair the body's response to the COVID-19

Vaccines designed for virus variants show promise in mice

By Reuters Staff (Reuters) - Moderna Inc vaccines designed to protect against the worrisome coronavirus variants identified in South Africa and Brazil have yielded promising results when tested in

UPDATE 1-Denmark looking to share its unwanted AstraZeneca vaccines-WHO

(Adds number of vaccines, no comment from ministry, changes "poorer" to "other" in first paragraph) By Reuters Staff ZURICH (Reuters) - Denmark is examining options for sharing AstraZeneca's vaccines

EMA starts review of GSK's monoclonal antibody to treat COVID-19 patients

By Reuters Staff (Reuters) - The European Medicines Agency said on Thursday it is reviewing available data on the use of GlaxoSmithKline's monoclonal antibody to treat COVID-19 patients. The agency

Antibiotics in development not enough to tackle 'superbugs'- WHO

By Reuters Staff (Reuters) - None of the 43 antibiotics currently in development as well as recently approved medicines are enough to combat the increasing emergence and spread of antimicrobial

CureVac's COVID-19 vaccine attracts rising interest

By Ludwig Burger FRANKFURT (Reuters) - German biotech firm CureVac said it has seen the number of requests for its experimental COVID-19 vaccine increase over the past few days, as concerns over rare

Denmark looking to share its unwanted AstraZeneca vaccines-WHO

By Reuters Staff ZURICH (Reuters) - Denmark is examining options for sharing AstraZeneca's vaccines with poorer nations after it halted use of the shots over concerns about rare blood clots, the World

Two to a bed in Delhi hospital as India's COVID crisis spirals

By Danish Siddiqui and Alasdair Pal NEW DELHI (Reuters) - Gasping for air, two men wearing oxygen masks share a bed in a government hospital in India's capital New Delhi, victims of the country's

Virus variants inciting India's second surge, epidemiologists say

By Neha Arora and Shilpa Jamkhandikar NEW DELHI (Reuters) - The second surge of COVID-19 cases in India has swamped hospitals much faster than the first because mutations in the virus mean each

UPDATE 2-J&J COVID-19 vaccine in limbo as U.S. panel delays vote on resuming shots

(Adds details from Wednesday meeting, FDA comments) By Julie Steenhuysen and Manas Mishra WASHINGTON (Reuters) - Johnson & Johnson's COVID-19 vaccine remained in limbo on Wednesday evening as a U.S.

Neutrophil/lymphocyte ratio may be tied to survival in patients receiving immunotherapy for NSCLC brain metastases

By Marilynn Larkin NEW YORK (Reuters Health) - In patients with non-small cell lung cancer brain metastases (NSCLCBM) treated with immune-checkpoint inhibitors (ICIs) and upfront steroids, a low

UPDATE 1-U.S. advisory panel members wary of ending pause on J&J COVID-19 vaccine

(Recasts with details from meeting, adds FDA comments) By Julie Steenhuysen and Manas Mishra WASHINGTON (Reuters) - Members of a U.S. health panel on Wednesday voiced concern over resuming

Intrapartum group B Streptococcus prophylaxis not tied to childhood allergic disorders

By Lisa Rapaport (Reuters Health) - Maternal intrapartum group B Streptococcus antibiotic prophylaxis isn't associated with an increased risk for diagnosis of allergic disorders such as asthma, eczema

Prosecutors grill defense expert who said George Floyd died from heart disease, exhaust fumes

By Jonathan Allen MINNEAPOLIS (Reuters) - A medical expert who testified in defense of former Minneapolis police officer Derek Chauvin, saying he believed that George Floyd's death was the result of

Disparities in child obesity widen during COVID-19 pandemic

By Lisa Rapaport (Reuters Health) - Disparities in obesity rates among children 2 to 17 years old before the COVID-19 pandemic appear to have widened since the onset of the pandemic, according to a

Seniors trust online doctor reviews almost as much as family and friends' recommendations

By Linda Carroll (Reuters Health) - Many older Americans are turning to online reviews and a goodly proportion of them trust those online reviews nearly as much as they trust the opinions of family

Small phase 2 study suggests magic-mushroom drug as good as escitalopram for depression

By Gene Emery NEW YORK (Reuters Health) - The psychedelic ingredient in so-called magic mushrooms reduced depression at least as well as the established antidepressant escitalopram and did it faster

Sinus inflammation may inhibit aspects of brain connectivity

By David Douglas NEW YORK (Reuters Health) - People with sinonasal inflammation show decreased functional brain connectivity, according to a small proof-of-concept study. "We have known for a long

Oral microbiome linked to COVID-10 diagnosis

By Marilynn Larkin NEW YORK (Reuters Health) - Oral microbial markers may be a potential diagnostic tool for COVID-19, researchers suggest. As reported in Gut, Dr. Lanjuan Li of Zhengzhou University

U.S. intelligence chief: spy agencies do not know exactly when COVID-19 first transmitted

By Reuters Staff WASHINGTON (Reuters) - Director of National Intelligence Avril Haines said on Wednesday that U.S. intelligence agencies do not know exactly when or how COVID-19 was initially

Fauci says pause on J&J COVID-19 shot should not prompt vaccine hesitancy

By Carl O'Donnell and Jarrett Renshaw (Reuters) - Top U.S. health officials urged Americans to get vaccinated against COVID-19 on Wednesday, saying U.S. regulators' pause on Johnson & Johnson shots,

Empty middle airplane seat could cut coronavirus exposure by up to 57% - CDC

By Reuters Staff (Reuters) - A vacant middle airplane seat could cut the risk of exposure to coronavirus by 23% to 57% compared with a full flight, according to a study on physical distancing onboard

Brazil's P1 coronavirus variant mutating, may become more dangerous -study

By Pedro Fonseca RIO DE JANEIRO (Reuters) - Brazil's P1 coronavirus variant, behind a deadly COVID-19 surge in the Latin American country that has raised international alarm, is mutating in ways that

Healthcare collapse imminent, Brazil's Sao Paulo warns, as COVID-19 cases surge

By Eduardo Simões and Lisandra Paraguassu SAO PAULO/BRASILIA (Reuters) - Brazil's richest and most populous state, Sao Paulo, has warned its ability to care for seriously ill COVID-19 patients was on

More evidence that gum disease may play a role in Alzheimer's disease

By Megan Brooks NEW YORK (Reuters Health) - Older cognitively healthy adults with more harmful than healthy bacteria in their gums are more likely to have biomarkers of amyloidosis in their

HDL anti-inflammatory capacity yields greater insight into heart-disease risk

By Megan Brooks NEW YORK (Reuters Health) - For cardiovascular disease (CVD) risk prediction, the anti-inflammatory capacity of high-density lipoprotein (HDL) cholesterol may be more important than

Add-on copanlisib prolongs life in relapsed, indolent non-Hodgkin lymphoma

By Megan Brooks NEW YORK (Reuters Health) - Adding copanlisib to standard rituximab therapy led to significant improvement in progression-free survival (PFS) in patients with relapsed indolent

EU countries move towards COVID passes to reopen summer travel

By Reuters Staff BRUSSELS (Reuters) - European Union countries formally agreed on Wednesday to launch COVID travel passes as a step towards reopening to tourism this summer and will negotiate details

INSIGHT-Biden to cancel Trump's pandemic food aid after high costs, delivery problems

By Christopher Walljasper CHICAGO (Reuters) - Yogurt was everywhere as volunteers opened boxes of fruit, frozen meat and dairy products that had shifted and spilled in transit to a food bank in

CanSinoBIO says no serious blood clots from its vaccine

By Reuters Staff (Reuters) - China's CanSino Biologics Inc said on Wednesday that no serious blood clot cases had been reported in people inoculated with its single-dose COVID-19 vaccine. U.S. federal

EU Commission to end AstraZeneca and J&J vaccine contracts at expiry - paper

By Reuters Staff MILAN (Reuters) - The EU Commission has decided not to renew COVID-19 vaccine contracts next year with AstraZeneca and Johnson & Johnson (J&J), Italian daily La Stampa reported on

In world first, Denmark ditches AstraZeneca's COVID-19 shot

By Nikolaj Skydsgaard and Jacob Gronholt-Pedersen COPENHAGEN (Reuters) - Denmark on Wednesday became the first country to stop using AstraZeneca's COVID-19 vaccine altogether, following news of its

U.S. CDC to weigh rare clot risk with J&J's COVID-19 vaccine as use paused

By Reuters Staff WASHINGTON (Reuters) - A U.S. health advisory panel on Wednesday is set to review six reported cases of rare blood clots in women who received Johnson & Johnson's COVID-19 vaccine one

Elderly show similar antibody response to 1st dose of Astra, Pfizer COVID-19 shots -UK study

By Kate Kelland LONDON (Reuters) - The first study to directly compare immune reactions between Pfizer's and AstraZeneca's COVID-19 vaccines found strong and broadly similar antibody responses in over

Healthy young adults may work-out less intensely wearing cloth masks

By Linda Carroll (Reuters Health) - Cloth masks worn by healthy young adults during intense workouts leads to lower exercise capacity and greater perceived discomfort, a small study suggests. An

Majority of Brazil COVID-19 ICU patients aged 40 years or younger - report

By Reuters Staff RIO DE JANEIRO (Reuters) - The surging COVID-19 outbreak in Brazil is increasingly affecting younger people, with hospital data showing that last month the majority of those in

One in four parents say youth sports don't consistently enforce COVID-19 precautions

By Lisa Rapaport (Reuters Health) - Even though the majority of parents give youth sports leagues high marks for keeping them informed about COVID-19 safety protocols, more than one in four parents

Self-report smell loss tool could be useful for COVID-19 symptom screening

By Marilynn Larkin NEW YORK (Reuters Health) - A novel self-administered olfactory test, SCENTinel, identifies individuals with smell loss and will likely be useful for COVID-19 symptom screening and

U.S. FDA to scrutinize vaccine design behind COVID-19 shots linked to blood clots

By Julie Steenhuysen and Kate Kelland CHICAGO/LONDON (Reuters) - With two COVID-19 vaccines now under scrutiny for possible links to very rare cases of blood clots in the brain, U.S. government

Comfort care for stroke on the rise in the U.S., tied to lower costs

By Marilynn Larkin NEW YORK (Reuters Health) - Comfort-care interventions among ischemic-stroke patients increased in the U.S. from 2006 to 2015 and were associated with lower adjusted costs,

Moderna says protection from its COVID-19 vaccine still strong six months on

By Michael Erman NEW YORK (Reuters) - Moderna Inc said on Tuesday that its COVID-19 vaccine still showed strong protection against the illness six months after people received their second shot, with

Breastfeeding safe for mothers with COVID-19 infection

By Reuters Staff NEW YORK (Reuters Health) - SARS-CoV-2 is unlikely to be transmitted to newborns via breast milk, according to a study from Israel, which supports the current guidance from the World

UPDATE 1-Ohio can enforce ban on Down syndrome abortions - U.S. appeals court

(Adds detail, Ohio attorney general comment) By Jonathan Stempel (Reuters) - A federal appeals court ruled on Tuesday that Ohio can enforce a 2017 law banning abortions when medical tests show that a

Mexican-made COVID-19 vaccine could be ready this year

By Cassandra Garrison MEXICO CITY (Reuters) - Mexico aims to have developed a vaccine against COVID-19 that could be granted approval for emergency use this year, a senior official said on Tuesday, an

BPCA-funded studies have racial, ethnic diversity

By Lisa Rapaport (Reuters Health) - Studies and clinical trials funded by the Best Pharmaceuticals for Children Act (BPCA) generally enroll youth from a variety of racial and ethnic groups at

South Africa suspends J&J vaccine rollout after U.S. pause

By Alexander Winning JOHANNESBURG (Reuters) - South Africa has suspended the rollout of Johnson & Johnson's (J&J) COVID-19 vaccine, its health minister said on Tuesday, after U.S. federal health

Canada talking to J&J about vaccine setback as PM frets over virus variants

By Steve Scherer and David Ljunggren OTTAWA (Reuters) - Canada said on Tuesday it was talking to Johnson & Johnson about reports that its COVID-19 vaccine might cause rare blood clots, while Prime

EU seeking clarification from J&J after rollout delay news - source

By Francesco Guarascio BRUSSELS (Reuters) - The European Commission is seeking clarification from Johnson & Johnson about the company's "completely unexpected" announcement of delays in COVID-19

Sweden's COVID infections among highest in Europe, with 'no sign of decrease'

By Johan Ahlander STOCKHOLM (Reuters) - The rate of new COVID-19 infections in Sweden has jumped to the second-highest in Europe after land-locked San Marino, data showed on Tuesday, as the

Austrian health minister says he is stepping down, exhausted

By Reuters Staff VIENNA (Reuters) - Austrian Health Minister Rudolf Anschober of the Greens, the junior partner in the conservative-led coalition, said on Tuesday he is stepping down, exhausted and

Ohio can enforce ban on Down syndrome abortions - U.S. appeals court

By Reuters Staff (Reuters) - A federal appeals court ruled on Tuesday that Ohio can enforce a 2017 law banning abortions when medical tests show that a fetus has Down syndrome. In a 9-7 decision, the

How computer mapping could help Biden find and fix polluted neighborhoods

By Valerie Volcovici (Reuters) - Diagnosed with asthma at 8 years old, Karlaine Francisco grew up thinking everyone had it. Her friends in south Stockton, California, also carried inhalers and

UPDATE 3-U.S. calls for pause to J&J COVID-19 vaccine over rare blood clots

(Adds more FDA comments) By Manas Mishra and Michael Erman (Reuters) - U.S. federal health agencies on Tuesday recommended pausing the use of Johnson & Johnson's COVID-19 vaccine for at least a few

Still not enough evidence to support or reject screening adults for vitamin D deficiency: USPSTF

By Reuters Staff NEW YORK (Reuters Health) - There remains insufficient evidence to recommend for or against screening for vitamin D deficiency in asymptomatic adults, according to an update from the

Pembrolizumab may be preferable to chemo in certain patients with gastroesophageal cancer

By David Douglas NEW YORK (Reuters Health) - Pembrolizumab may have an edge on chemotherapy for microsatellite instability-high (MSI-H) advanced gastric or gastroesophageal-junction cancer, according

Healthy lifestyle may protect against lethal prostate cancer in men at high genetic risk

By Megan Brooks NEW YORK (Reuters Health) - Maintaining a healthy lifestyle may reduce the risk of lethal prostate cancer in men at high genetic risk for developing the disease, according to new

Pubmed articles

In order to help keep you abreast of current research we offer our PubMed feed. This section features the most recently published peer-reviewed studies in the 10 most common disease states.

Medical Jobs

Search healthcare jobs by specialty or location.

© 2021 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information